Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling
The first rate-limiting enzyme of the serine synthesis pathway (SSP), phosphoglycerate dehydrogenase (PHGDH), is hyperactive in multiple tumors, which leads to the activation of SSP and promotes tumorigenesis. However, only a few inhibitors of PHGDH have been discovered to date, especially the coval...
Saved in:
Main Authors: | Chen Chen (Author), Tianyu Zhu (Author), Xiaoqin Liu (Author), Dongrong Zhu (Author), Yi Zhang (Author), Sifang Wu (Author), Chao Han (Author), Hao Zhang (Author), Jianguang Luo (Author), Lingyi Kong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular glue triggers degradation of PHGDH by enhancing the interaction between DDB1 and PHGDH
by: Ziqi Huang, et al.
Published: (2024) -
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
by: He Zhang, et al.
Published: (2023) -
A targeted covalent inhibitor of p97 with proteome-wide selectivity
by: Zi Ye, et al.
Published: (2022) -
Pharmacokinetic study and metabolite identification of the bidesmosidic triterpenoid saponin BTS-1 in rat plasma
by: Jianguang Luo, et al.
Published: (2013) -
Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
by: Kaixuan Wang, et al.
Published: (2023)